Komori
Earnings presentation2183Linical Co.,Ltd.Information and Communications, Services and Others

Supplementary Explanatory Materials for the First Quarter Financial Results for the Fiscal Year Ending March 2027

In the first quarter, consolidated revenue fell 27.2% year on year due to lower revenue in Japan, the United States and Europe, while the operating loss widened from ¥104 million to ¥719 million. In contrast, South Korea and Taiwan reported higher revenue and profit, driven by new projects and progress on existing projects.

Worth reading
41Recurring
Scored from 5 of 6 sections
Direction
Deterioration
Direction inferred from the company’s description.
Scale
-714
¥ million (year-on-year decrease in revenue)
Wording
Conditional
How definitive the wording is.

Contents of this document

Supplementary materials to the earnings reportFirst quarter of the fiscal year ending March 20275 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥1,912 million-27.2%
Operating profit¥-719 million
Ordinary income¥-700 million
Net income¥-636 million
Selling, general and administrative expenses¥775 million
Operating profit margin
Fiscal year ending March 2026, 1Q-4
Fiscal year ending March 2027, 1Q-37.6
Full-year earnings forecast
Net Sales
¥10,680 million
Operating profit
¥256 million
Ordinary income
¥250 million
Net income for the current fiscal year
¥180 million
Dividend per share
¥8
What the company explained in this material
New initiatives
  • Focus on sales activities to build order backlog
  • Further strengthen global synergies, centered on the U.S. business
Key KPIsA metric the company considers important as a management benchmark.
  • Order backlog¥117 million
  • Percentage change in order backlog from the end of the fiscal year ending March 20261.1 %
Segment results
Japan
Net Sales
¥890 million-7.2%
Operating profit
¥-250 million
Ordinary income
¥-217 million
United States
Net Sales
¥460 million-62.5%
Operating profit
¥-230 million
Ordinary income
¥-231 million
Europe
Net Sales
¥636 million-33.2%
Operating profit
¥-209 million
Ordinary income
¥-213 million
South Korea
Net Sales
¥257 million+90.6%
Operating profit
¥62 million
Ordinary income
¥60 million
Taiwan
Net Sales
¥74 million+102.8%
Operating profit
¥13 million
Ordinary income
¥13 million
China
Net Sales
¥46 million+1.7%
Operating profit
¥-15 million
Ordinary income
¥-17 million
Consolidated adjustments
Net Sales
¥-452 million
Operating profit
¥-89 million
Ordinary income
¥-95 million
Orders received and order backlog
Order backlog¥117 million
Record date14 August 2026
Annual Dividend
Annual dividend per share¥8
Contents of this document
ItemDetails
Document typeSupplementary materials to the earnings report
Fiscal Period CoveredFirst quarter of the fiscal year ending March 2027
Net Sales¥1,912 million (YoY -27.2%)
Operating profit¥-719 million
Ordinary income¥-700 million
Net income¥-636 million
Operating profit marginFiscal year ending March 2026, 1Q -4 / Fiscal year ending March 2027, 1Q -37.6 / Year-on-year change (points) Not disclosed
Selling, general and administrative expenses¥775 million
Full-year earnings forecastNet Sales ¥10,680 million / Operating profit ¥256 million / Ordinary income ¥250 million / Net income for the current fiscal year ¥180 million / Dividend per share ¥8
Segment resultsJapan Net Sales ¥890 million (YoY -7.2%) / Operating profit ¥-250 million / Ordinary income ¥-217 million / United States Net Sales ¥460 million (YoY -62.5%) / Operating profit ¥-230 million / Ordinary income ¥-231 million / Europe Net Sales ¥636 million (YoY -33.2%) / Operating profit ¥-209 million / Ordinary income ¥-213 million / South Korea Net Sales ¥257 million (YoY +90.6%) / Operating profit ¥62 million / Ordinary income ¥60 million / Taiwan Net Sales ¥74 million (YoY +102.8%) / Operating profit ¥13 million / Ordinary income ¥13 million / China Net Sales ¥46 million (YoY +1.7%) / Operating profit ¥-15 million / Ordinary income ¥-17 million / Consolidated adjustments Net Sales ¥-452 million / Operating profit ¥-89 million / Ordinary income ¥-95 million
Key KPIsIndicator name Order backlog / Value ¥117 million / Year on year against the same period last year Not disclosed, Indicator name Percentage change in order backlog from the end of the fiscal year ending March 2026 / Value 1.1 % / Year on year against the same period last year Not disclosed
Annual DividendAnnual dividend per share ¥8 / Interim and Year-End Breakdown Not disclosed
Orders received and order backlogOrder backlog ¥117 million / Record date 14 August 2026
New initiativesFocus on sales activities to build order backlog, Further strengthen global synergies, centered on the U.S. business
Items this document does not state (17)
Gross Profit MarginResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsPayout ratioAcquisition of treasury sharesCapital expendituresMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue declined in Japan due to challenging market conditions and the downsizing of existing projects, in the United States due to the impact of government shutdowns and other factors, as well as adjustments to contract terms, and in Europe because full-scale operations will begin in the second quarter or later. The decline in revenue in the United States and Europe resulted in an operating loss, while Japan continued to report an operating loss.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Explanatory Materials for the First Quarter Financial Results for the Fiscal Year Ending March 2027 | Linical Co.,Ltd. (2183) timely disclosure | Komori